220 related articles for article (PubMed ID: 27183828)
1. Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study.
Peng SS; Hwu WL; Lee NC; Tsai FJ; Tsai WH; Chien YH
Orphanet J Rare Dis; 2016 May; 11(1):63. PubMed ID: 27183828
[TBL] [Abstract][Full Text] [Related]
2. Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth.
Chien YH; Lee NC; Chen CA; Tsai FJ; Tsai WH; Shieh JY; Huang HJ; Hsu WC; Tsai TH; Hwu WL
J Pediatr; 2015 Apr; 166(4):985-91.e1-2. PubMed ID: 25466677
[TBL] [Abstract][Full Text] [Related]
3. Muscle MRI of classic infantile pompe patients: Fatty substitution and edema-like changes.
Pichiecchio A; Rossi M; Cinnante C; Colafati GS; De Icco R; Parini R; Menni F; Furlan F; Burlina A; Sacchini M; Donati MA; Fecarotta S; Casa RD; Deodato F; Taurisano R; Di Rocco M
Muscle Nerve; 2017 Jun; 55(6):841-848. PubMed ID: 27668838
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
Nuñez-Peralta C; Alonso-Pérez J; Llauger J; Segovia S; Montesinos P; Belmonte I; Pedrosa I; Montiel E; Alonso-Jiménez A; Sánchez-González J; Martínez-Noguera A; Illa I; Díaz-Manera J
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1032-1046. PubMed ID: 32129012
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle magnetic resonance imaging in Pompe disease.
Díaz-Manera J; Walter G; Straub V
Muscle Nerve; 2021 May; 63(5):640-650. PubMed ID: 33155691
[TBL] [Abstract][Full Text] [Related]
6. Severe distal muscle involvement and mild sensory neuropathy in a boy with infantile onset Pompe disease treated with enzyme replacement therapy for 6 years.
Schänzer A; Görlach J; Claudi K; Hahn A
Neuromuscul Disord; 2019 Jun; 29(6):477-482. PubMed ID: 31101460
[TBL] [Abstract][Full Text] [Related]
7. Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy.
Lollert A; Stihl C; Hötker AM; Mengel E; König J; Laudemann K; Gökce S; Düber C; Staatz G
PLoS One; 2018; 13(1):e0190784. PubMed ID: 29315315
[TBL] [Abstract][Full Text] [Related]
8. 2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease.
Plöckinger U; Prasad V; Ziagaki A; Tiling N; Poellinger A
Hum Genomics; 2018 Mar; 12(1):14. PubMed ID: 29523196
[TBL] [Abstract][Full Text] [Related]
9. Airway abnormalities in very early treated infantile-onset Pompe disease: A large-scale survey by flexible bronchoscopy.
Yang CF; Niu DM; Tai SK; Wang TH; Su HT; Huang LY; Soong WJ
Am J Med Genet A; 2020 Apr; 182(4):721-729. PubMed ID: 31953985
[TBL] [Abstract][Full Text] [Related]
10. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
[TBL] [Abstract][Full Text] [Related]
11. Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state.
Matsuoka T; Miwa Y; Tajika M; Sawada M; Fujimaki K; Soga T; Tomita H; Uemura S; Nishino I; Fukuda T; Sugie H; Kosuga M; Okuyama T; Umeda Y
Mol Genet Metab Rep; 2016 Dec; 9():98-105. PubMed ID: 27896132
[TBL] [Abstract][Full Text] [Related]
12. Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease.
Kenney-Jung D; Korlimarla A; Spiridigliozzi GA; Wiggins W; Malinzak M; Nichting G; Jung SH; Sun A; Wang RY; Al Shamsi A; Phornphutkul C; Owens J; Provenzale JM; Kishnani PS
Mol Genet Metab; 2024 Feb; 141(2):108119. PubMed ID: 38184429
[TBL] [Abstract][Full Text] [Related]
13. Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy.
Chien YH; Lee NC; Peng SF; Hwu WL
Pediatr Res; 2006 Sep; 60(3):349-52. PubMed ID: 16857770
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal follow-up to evaluate speech disorders in early-treated patients with infantile-onset Pompe disease.
Zeng YT; Hwu WL; Torng PC; Lee NC; Shieh JY; Lu L; Chien YH
Eur J Paediatr Neurol; 2017 May; 21(3):485-493. PubMed ID: 28039015
[TBL] [Abstract][Full Text] [Related]
15. Pompe disease: early diagnosis and early treatment make a difference.
Chien YH; Hwu WL; Lee NC
Pediatr Neonatol; 2013 Aug; 54(4):219-27. PubMed ID: 23632029
[TBL] [Abstract][Full Text] [Related]
16. Should patients with asymptomatic pompe disease be treated? A nationwide study in France.
Echaniz-Laguna A; Carlier RY; Laloui K; Carlier P; Salort-Campana E; Pouget J; Laforet P
Muscle Nerve; 2015 Jun; 51(6):884-9. PubMed ID: 25786784
[TBL] [Abstract][Full Text] [Related]
17. Trunk muscle involvement in late-onset Pompe disease: study of thirty patients.
Alejaldre A; Díaz-Manera J; Ravaglia S; Tibaldi EC; D'Amore F; Morís G; Muelas N; Vílchez JJ; García-Medina A; Usón M; Martínez García FA; Illa I; Pichiecchio A
Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S148-54. PubMed ID: 22980766
[TBL] [Abstract][Full Text] [Related]
18. Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain.
Ebbink BJ; Poelman E; Aarsen FK; Plug I; Régal L; Muentjes C; van der Beek NAME; Lequin MH; van der Ploeg AT; van den Hout JMP
Dev Med Child Neurol; 2018 Jun; 60(6):579-586. PubMed ID: 29573408
[TBL] [Abstract][Full Text] [Related]
19. High-density CT of muscle and liver may allow early diagnosis of childhood-onset Pompe disease.
Ishigaki K; Yoshikawa Y; Kuwatsuru R; Oda E; Murakami T; Sato T; Saito T; Umezu R; Osawa M
Brain Dev; 2012 Feb; 34(2):103-6. PubMed ID: 21704464
[TBL] [Abstract][Full Text] [Related]
20. Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease.
Kishnani PS; Nicolino M; Voit T; Rogers RC; Tsai AC; Waterson J; Herman GE; Amalfitano A; Thurberg BL; Richards S; Davison M; Corzo D; Chen YT
J Pediatr; 2006 Jul; 149(1):89-97. PubMed ID: 16860134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
